Global Drug of Abuse (DOA) Testing Market Size, Status and Forecast 2021-2027

1 Report Overview

• 1.1 Study Scope
• 1.2 Market Analysis by Type
  • 1.2.1 Global Drug of Abuse (DOA) Testing Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
  • 1.2.2 Urine
  • 1.2.3 Saliva
  • 1.2.4 Hair
  • 1.2.5 Others
• 1.3 Market by Application
  • 1.3.1 Global Drug of Abuse (DOA) Testing Market Share by Application: 2016 VS 2021 VS 2027
  • 1.3.2 Hospitals
  • 1.3.3 Laboratories
  • 1.3.4 Workplace
  • 1.3.5 At-Home
  • 1.3.6 Others
• 1.4 Study Objectives
• 1.5 Years Considered

2 Global Growth Trends

• 2.1 Global Drug of Abuse (DOA) Testing Market Perspective (2016-2027)
• 2.2 Drug of Abuse (DOA) Testing Growth Trends by Regions
  • 2.2.1 Drug of Abuse (DOA) Testing Market Size by Regions: 2016 VS 2021 VS 2027
  • 2.2.2 Drug of Abuse (DOA) Testing Historic Market Share by Regions (2016-2021)
  • 2.2.3 Drug of Abuse (DOA) Testing Forecasted Market Size by Regions (2022-2027)
• 2.3 Drug of Abuse (DOA) Testing Industry Dynamic
  • 2.3.1 Drug of Abuse (DOA) Testing Market Trends
  • 2.3.2 Drug of Abuse (DOA) Testing Market Drivers
  • 2.3.3 Drug of Abuse (DOA) Testing Market Challenges
  • 2.3.4 Drug of Abuse (DOA) Testing Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Top Drug of Abuse (DOA) Testing Players by Revenue
  • 3.1.1 Global Top Drug of Abuse (DOA) Testing Players by Revenue (2016-2021)
  • 3.1.2 Global Drug of Abuse (DOA) Testing Revenue Market Share by Players (2016-2021)
• 3.2 Global Drug of Abuse (DOA) Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.3 Players Covered: Ranking by Drug of Abuse (DOA) Testing Revenue
• 3.4 Global Drug of Abuse (DOA) Testing Market Concentration Ratio
  • 3.4.1 Global Drug of Abuse (DOA) Testing Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by Drug of Abuse (DOA) Testing Revenue in 2020
• 3.5 Drug of Abuse (DOA) Testing Key Players Head office and Area Served
• 3.6 Key Players Drug of Abuse (DOA) Testing Product Solution and Service
• 3.7 Date of Enter into Drug of Abuse (DOA) Testing Market
• 3.8 Mergers & Acquisitions, Expansion Plans

4 Drug of Abuse (DOA) Testing Breakdown Data by Type

• 4.1 Global Drug of Abuse (DOA) Testing Historic Market Size by Type (2016-2021)
• 4.2 Global Drug of Abuse (DOA) Testing Forecasted Market Size by Type (2022-2027)

5 Drug of Abuse (DOA) Testing Breakdown Data by Application

• 5.1 Global Drug of Abuse (DOA) Testing Historic Market Size by Application (2016-2021)
• 5.2 Global Drug of Abuse (DOA) Testing Forecasted Market Size by Application (2022-2027)

6 North America

• 6.1 North America Drug of Abuse (DOA) Testing Market Size (2016-2027)
• 6.2 North America Drug of Abuse (DOA) Testing Market Size by Type
  • 6.2.1 North America Drug of Abuse (DOA) Testing Market Size by Type (2016-2021)
  • 6.2.2 North America Drug of Abuse (DOA) Testing Market Size by Type (2022-2027)
  • 6.2.3 North America Drug of Abuse (DOA) Testing Market Size by Type (2016-2027)
• 6.3 North America Drug of Abuse (DOA) Testing Market Size by Application
  • 6.3.1 North America Drug of Abuse (DOA) Testing Market Size by Application (2016-2021)
  • 6.3.2 North America Drug of Abuse (DOA) Testing Market Size by Application (2022-2027)
  • 6.3.3 North America Drug of Abuse (DOA) Testing Market Size by Application (2016-2027)
• 6.4 North America Drug of Abuse (DOA) Testing Market Size by Country
  • 6.4.1 North America Drug of Abuse (DOA) Testing Market Size by Country (2016-2021)
  • 6.4.2 North America Drug of Abuse (DOA) Testing Market Size by Country (2022-2027)
  • 6.4.3 United States
  • 6.4.3 Canada

7 Europe

• 7.1 Europe Drug of Abuse (DOA) Testing Market Size (2016-2027)
• 7.2 Europe Drug of Abuse (DOA) Testing Market Size by Type
  • 7.2.1 Europe Drug of Abuse (DOA) Testing Market Size by Type (2016-2021)
  • 7.2.2 Europe Drug of Abuse (DOA) Testing Market Size by Type (2022-2027)
  • 7.2.3 Europe Drug of Abuse (DOA) Testing Market Size by Type (2016-2027)
• 7.3 Europe Drug of Abuse (DOA) Testing Market Size by Application
  • 7.3.1 Europe Drug of Abuse (DOA) Testing Market Size by Application (2016-2021)
  • 7.3.2 Europe Drug of Abuse (DOA) Testing Market Size by Application (2022-2027)
  • 7.3.3 Europe Drug of Abuse (DOA) Testing Market Size by Application (2016-2027)
• 7.4 Europe Drug of Abuse (DOA) Testing Market Size by Country
  • 7.4.1 Europe Drug of Abuse (DOA) Testing Market Size by Country (2016-2021)
  • 7.4.2 Europe Drug of Abuse (DOA) Testing Market Size by Country (2022-2027)
  • 7.4.3 Germany
  • 7.4.4 France
  • 7.4.5 U.K.
  • 7.4.6 Italy
  • 7.4.7 Russia
  • 7.4.8 Nordic

8 Asia-Pacific

• 8.1 Asia-Pacific Drug of Abuse (DOA) Testing Market Size (2016-2027)
• 8.2 Asia-Pacific Drug of Abuse (DOA) Testing Market Size by Type
  • 8.2.1 Asia-Pacific Drug of Abuse (DOA) Testing Market Size by Type (2016-2021)
  • 8.2.2 Asia-Pacific Drug of Abuse (DOA) Testing Market Size by Type (2022-2027)
  • 8.2.3 Asia-Pacific Drug of Abuse (DOA) Testing Market Size by Type (2016-2027)
• 8.3 Asia-Pacific Drug of Abuse (DOA) Testing Market Size by Application
  • 8.3.1 Asia-Pacific Drug of Abuse (DOA) Testing Market Size by Application (2016-2021)
  • 8.3.2 Asia-Pacific Drug of Abuse (DOA) Testing Market Size by Application (2022-2027)
  • 8.3.3 Asia-Pacific Drug of Abuse (DOA) Testing Market Size by Application (2016-2027)
• 8.4 Asia-Pacific Drug of Abuse (DOA) Testing Market Size by Region
  • 8.4.1 Asia-Pacific Drug of Abuse (DOA) Testing Market Size by Region (2016-2021)
  • 8.4.2 Asia-Pacific Drug of Abuse (DOA) Testing Market Size by Region (2022-2027)
  • 8.4.3 China
  • 8.4.4 Japan
  • 8.4.5 South Korea
  • 8.4.6 Southeast Asia
  • 8.4.7 India
  • 8.4.8 Australia

9 Latin America

• 9.1 Latin America Drug of Abuse (DOA) Testing Market Size (2016-2027)
• 9.2 Latin America Drug of Abuse (DOA) Testing Market Size by Type
  • 9.2.1 Latin America Drug of Abuse (DOA) Testing Market Size by Type (2016-2021)
  • 9.2.2 Latin America Drug of Abuse (DOA) Testing Market Size by Type (2022-2027)
  • 9.2.3 Latin America Drug of Abuse (DOA) Testing Market Size by Type (2016-2027)
• 9.3 Latin America Drug of Abuse (DOA) Testing Market Size by Application
  • 9.3.1 Latin America Drug of Abuse (DOA) Testing Market Size by Application (2016-2021)
  • 9.3.2 Latin America Drug of Abuse (DOA) Testing Market Size by Application (2022-2027)
  • 9.3.3 Latin America Drug of Abuse (DOA) Testing Market Size by Application (2016-2027)
• 9.4 Latin America Drug of Abuse (DOA) Testing Market Size by Country
  • 9.4.1 Latin America Drug of Abuse (DOA) Testing Market Size by Country (2016-2021)
  • 9.4.2 Latin America Drug of Abuse (DOA) Testing Market Size by Country (2022-2027)
  • 9.4.3 Mexico
  • 9.4.4 Brazil

10 Middle East & Africa

• 10.1 Middle East & Africa Drug of Abuse (DOA) Testing Market Size (2016-2027)
• 10.2 Middle East & Africa Drug of Abuse (DOA) Testing Market Size by Type
  • 10.2.1 Middle East & Africa Drug of Abuse (DOA) Testing Market Size by Type (2016-2021)
  • 10.2.2 Middle East & Africa Drug of Abuse (DOA) Testing Market Size by Type (2022-2027)
  • 10.2.3 Middle East & Africa Drug of Abuse (DOA) Testing Market Size by Type (2016-2027)
• 10.3 Middle East & Africa Drug of Abuse (DOA) Testing Market Size by Application
  • 10.3.1 Middle East & Africa Drug of Abuse (DOA) Testing Market Size by Application (2016-2021)
  • 10.3.2 Middle East & Africa Drug of Abuse (DOA) Testing Market Size by Application (2022-2027)
  • 10.3.3 Middle East & Africa Drug of Abuse (DOA) Testing Market Size by Application (2016-2027)
• 10.4 Middle East & Africa Drug of Abuse (DOA) Testing Market Size by Country
  • 10.4.1 Middle East & Africa Drug of Abuse (DOA) Testing Market Size by Country (2016-2021)
  • 10.4.2 Middle East & Africa Drug of Abuse (DOA) Testing Market Size by Country (2022-2027)
  • 10.4.3 Turkey
  • 10.4.4 Saudi Arabia
  • 10.4.5 UAE

11 Key Players Profiles

• 11.1 Siemens
  • 11.1.1 Siemens Company Details
  • 11.1.2 Siemens Business Overview
  • 11.1.3 Siemens Drug of Abuse (DOA) Testing Introduction
  • 11.1.4 Siemens Revenue in Drug of Abuse (DOA) Testing Business (2016-2021)
  • 11.1.5 Siemens Recent Development
• 11.2 Merck
  • 11.2.1 Merck Company Details
  • 11.2.2 Merck Business Overview
  • 11.2.3 Merck Drug of Abuse (DOA) Testing Introduction
  • 11.2.4 Merck Revenue in Drug of Abuse (DOA) Testing Business (2016-2021)
  • 11.2.5 Merck Recent Development
• 11.3 Roche
  • 11.3.1 Roche Company Details
  • 11.3.2 Roche Business Overview
  • 11.3.3 Roche Drug of Abuse (DOA) Testing Introduction
  • 11.3.4 Roche Revenue in Drug of Abuse (DOA) Testing Business (2016-2021)
  • 11.3.5 Roche Recent Development
• 11.4 Thermo Fisher Scientific
  • 11.4.1 Thermo Fisher Scientific Company Details
  • 11.4.2 Thermo Fisher Scientific Business Overview
  • 11.4.3 Thermo Fisher Scientific Drug of Abuse (DOA) Testing Introduction
  • 11.4.4 Thermo Fisher Scientific Revenue in Drug of Abuse (DOA) Testing Business (2016-2021)
  • 11.4.5 Thermo Fisher Scientific Recent Development
• 11.5 Bio-Rad
  • 11.5.1 Bio-Rad Company Details
  • 11.5.2 Bio-Rad Business Overview
  • 11.5.3 Bio-Rad Drug of Abuse (DOA) Testing Introduction
  • 11.5.4 Bio-Rad Revenue in Drug of Abuse (DOA) Testing Business (2016-2021)
  • 11.5.5 Bio-Rad Recent Development
• 11.6 Abbott
  • 11.6.1 Abbott Company Details
  • 11.6.2 Abbott Business Overview
  • 11.6.3 Abbott Drug of Abuse (DOA) Testing Introduction
  • 11.6.4 Abbott Revenue in Drug of Abuse (DOA) Testing Business (2016-2021)
  • 11.6.5 Abbott Recent Development
• 11.7 Quest Diagnostics
  • 11.7.1 Quest Diagnostics Company Details
  • 11.7.2 Quest Diagnostics Business Overview
  • 11.7.3 Quest Diagnostics Drug of Abuse (DOA) Testing Introduction
  • 11.7.4 Quest Diagnostics Revenue in Drug of Abuse (DOA) Testing Business (2016-2021)
  • 11.7.5 Quest Diagnostics Recent Development
• 11.8 Psychemedics
  • 11.8.1 Psychemedics Company Details
  • 11.8.2 Psychemedics Business Overview
  • 11.8.3 Psychemedics Drug of Abuse (DOA) Testing Introduction
  • 11.8.4 Psychemedics Revenue in Drug of Abuse (DOA) Testing Business (2016-2021)
  • 11.8.5 Psychemedics Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
  • 13.1.2 Data Source
• 13.2 Disclaimer